“Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma”, J. Can. Res. Updates, vol. 15, no. 3, pp. 197–205, Jul. 2026, doi: 10.30683/1929-2279.2026.15.18.